PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer, and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort: COVID Moonshot.